Search results
Steven K. Galson, a former senior vice president of Global Regulatory Affairs and Safety, joined Amgen as vice president of Global Regulatory Affairs in 2010. Prior to Amgen, Galson was senior vice president for Civilian Health Operations and chief health scientist at Science Applications International Corporation.
Dr. Steven K. Galson, senior vice president, Global Regulatory Affairs and Safety, joined Amgen in 2010 as vice president, Global Regulatory Affairs. Prior to Amgen, Galson was senior vice president for Civilian Health Operations and chief health scientist at Science Applications International Corporation.
Steven K Galson. PMID: 19320357 PMCID: PMC2646471 DOI: 10.1177/003335490912400202 No abstract available. MeSH terms Cost of Illness ...
Oct 7, 2016 · In 2007, former Acting Surgeon General RADM Kenneth Moritsugu released The Surgeon General's Call to Action to Prevent and Reduce Underage Drinking 1 to let the American people know about the nature and extent of underage drinking and its consequences, defined in this article as alcohol consumption by people younger than the minimum legal drinking age of 21.
RADM Steven K. Galson, Acting Surgeon General FAREWELL MESSAGE FROM RADM STEVEN K. GALSON As our nation prepares to welcome a new Surgeon General, and I move forward in my professional journey, I would like to share my sense of honor and privilege to have served in this position for the past two years.
Steven Kenneth Galson (born 1956) is an American public health physician. He is currently Senior Vice President for Global Regulatory Affairs & Safety at Amgen, the California-based biopharmaceutical company. He is also Professor-at-Large at the Keck Graduate Institute for Applied Life Sciences in Clarmont, California. He is a retired rear admiral in the United States Public Health Service ...
Steven K. Galson, MD, MPH, is a consultant to Amgen and serves on the Board of Directors of Insilico Medicine and Biocryst Pharmaceuticals. Until June 2020 he was a senior vice president of Research and Development at Amgen. He joined the company in 2010 as vice president of Global Regulatory Affairs.
